CIK 0000887359 · Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 943096597
- Phone
- 6175885555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,787,802
- in 7 filings, $5.8M under 10b5-1 plans
Net −$5,787,802. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Mara Joseph Anthony Jr −$4.1M Chief Financial Officer sold 82% of stake
- Flynn Sean C. −$779K Chief Legal Officer sold 88% of stake
- MCLAUGHLIN KEVIN F −$413K Director sold 28% of stake
- ZERBE ROBERT L MD −$386K Director sold 19% of stake
- SIEGAL JONATHAN −$79K Principal Accounting Officer sold 54% of stake
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-26 | Hopper Jonathan Mark Chief Medical Officer | Sale 10b5-1 | −5,000 | $45.00 | $225K | 75,753 |
| 2026-06-26 | Hopper Jonathan Mark Chief Medical Officer | Option exercise 10b5-1 | +5,000 | $29.82 | $149K | 80,753 |
| 2026-06-26 | Hopper Jonathan Mark Chief Medical Officer | Sale 10b5-1 | −5,000 | $45.00 | $225K | 75,753 |
| 2026-06-26 | Hopper Jonathan Mark Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | +5,000 | 25,000 | ||
| 2026-06-26 | Hopper Jonathan Mark Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | +5,000 | 20,000 | ||
| 2026-06-26 | Flynn Sean C. Chief Legal Officer | Option exercise 10b5-1 | +15,000 | $16.25 | $244K | 16,647 |
| 2026-06-26 | Flynn Sean C. Chief Legal Officer | Sale 10b5-1 | −15,000 | $45.64 | $685K | 1,647 |
| 2026-06-26 | Flynn Sean C. Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | +15,000 | 55,000 | ||
| 2026-06-18 | Halpin Michael Chief Operating Officer | Option exercise 10b5-1 | +10,000 | $16.66 | $167K | 26,248 |
| 2026-06-18 | Halpin Michael Chief Operating Officer | Sale 10b5-1 | −10,000 | $40.24 | $402K | 16,248 |
| 2026-06-18 | Halpin Michael Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | +10,000 | 36,250 | ||
| 2026-06-18 | Flynn Sean C. Chief Legal Officer | Option exercise 10b5-1 | +15,000 | $16.25 | $244K | 16,647 |
| 2026-06-18 | Flynn Sean C. Chief Legal Officer | Sale 10b5-1 | −15,000 | $40.21 | $603K | 1,647 |
| 2026-06-18 | Flynn Sean C. Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | +15,000 | 70,000 | ||
| 2026-06-02 | Hopper Jonathan Mark Chief Medical Officer | Option exercise 10b5-1 | +4,375 | $16.66 | $73K | 80,128 |
| 2026-06-02 | Hopper Jonathan Mark Chief Medical Officer | Sale 10b5-1 | −4,375 | $35.00 | $153K | 75,753 |
| 2026-06-02 | Hopper Jonathan Mark Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | +4,375 | 1,625 | ||
| 2026-05-13 | MCLAUGHLIN KEVIN F Director | Option exercise 10b5-1 | +3,500 | $2.63 | $9K | 21,800 |
| 2026-05-13 | MCLAUGHLIN KEVIN F Director | Sale 10b5-1 | −3,500 | $32.83 | $115K | 18,300 |
| 2026-05-13 | MCLAUGHLIN KEVIN F Director | Option exercise 10b5-1 | +3,500 | $13.05 | $46K | 21,800 |
Page 4 of 75 · 1,497 trades